Suchergebnisse - "Kato, Hideo"

PubPharm (6)

1

Safety Evaluation of Remdesivir for COVID-19 Patients with eGFR < 30 mL/min without Renal Replacement Therapy in a Japanese Single-Center Study

enthalten in: Healthcare (Basel, Switzerland) | 2022

von Umemura, T. | Mutoh, Y. | Mizuno, T. | +6

2

The pathophysiological mechanisms of COVID-19 and host immunity, with emphasis on the dysbiosis of the lung and gut microbiomes and pregnancy

enthalten in: Respiratory investigation | 2022

von Asai, N. | Kato, H. | Mikamo, H.

3

Comparative study of SmartAmp assay and reverse transcription-polymerase chain reaction by saliva specimen for the diagnosing COVID-19

enthalten in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy | 2022

von Asai, N. | Nakamura, A. | Sakanashi, D. | +14

4

Clinical manifestations and radiological features by chest computed tomographic findings of a novel coronavirus disease-19 pneumonia among 92 patients in Japan

enthalten in: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi | 2021

von Asai, N. | Sakanashi, D. | Nakamura, A. | +7

5

Efficacy and validity of automated quantitative chemiluminescent enzyme immunoassay for SARS-CoV-2 antigen test from saliva specimen in the diagnosis of COVID-19

enthalten in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy | 2021

von Asai, N. | Sakanashi, D. | Ohashi, W. | +15

6

Could threshold cycle value correctly reflect the severity of novel coronavirus disease 2019 (COVID-19)?

enthalten in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy | 2021

von Asai, N. | Sakanashi, D. | Ohashi, W. | +14

1
[1]